Immunotherapy Approaches for Urothelial Bladder Cancer: Expert Guidance Through Challenging Cases Exploring the Fundamental Changes in Patient Care

In this downloadable slideset, Elizabeth R. Plimack, MD, MS, discusses the current clinical rationale and most recent data on immune checkpoint inhibitors for patients with advanced bladder cancer. Click here to use our online tool to see how to select optimal therapy for your patients.
Format: Microsoft PowerPoint (.ppt)
File Size: 7.79 MB
Released: April 30, 2018


This activity is supported by an educational grant from
Merck & Co., Inc.

Related Content

Download this PDF resource of expert recommendations on the optimal use of immune checkpoint inhibitors in patients with advanced NSCLC, including therapy selection and adverse event management.

Released: April 30, 2018

In this virtual presentation, Elizabeth R. Plimack, MD, MS discusses the clinical rationale and data on the use of immune checkpoint inhibitors for patients with advanced bladder cancer. Afterwards, download the slides and use the treatment decision tool for your practice.

Elizabeth R. Plimack, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Released: April 30, 2018 Expiration: April 29, 2019

Expert faculty from the 2017-2018 CCO Local Live meeting series “Expert Strategies to Optimize the Treatment of Patients With Squamous NSCLC” answer frequently asked questions about treating squamous NSCLC, including considerations regarding tumor mutational burden, optimal sequencing of therapy, and future directions.

Edward S. Kim, MD
Program Director
Mark A. Socinski, MD
Program Director
person default Paul K. Paik, MD Nathan Pennell, MD, PhD Thomas Stinchcombe, MD
Released: April 26, 2018

How will the new dosing schedule for nivolumab in NSCLC affect our current practice? Here are my thoughts.

Edward B. Garon, MD, MS Released: April 16, 2018

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?